Trials / Completed
CompletedNCT06433323
Biological Anti-aging Efficacy of a Cosmetic Night Cream
Evaluation of Biological Anti-aging Efficacy of the Cosmetic Night Cream RV4983A- LA3365 in Women After 2 Months of Daily Use
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Pierre Fabre Dermo Cosmetique · Industry
- Sex
- Female
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
In a previous study, the cosmetic night cream RV4983A- LA3365 has proven a great efficacy in reducing the clinical signs of skin aging, as well as a great tolerance. The skin structure and composition greatly evolve over the time, and deciphering the biological mechanisms by which the cosmetic night cream RV4983A- LA3365 reduces the signs of skin aging is therefore of great interest to deepen our efficacy evaluation and knowledge on skin aging biology.
Detailed description
An intra-individual, comparative study randomized will be conducted as monocentric trial in female adult 46 subjects are included 4 visits are planned: * Visit 1 (D1): Inclusion and 1st product application * Visit 2 (D28): Phone call follow-up * Visit 3 (D57): End of application and biopsies * Visit 4 (7 days after V3): Biopsies control and end-of-study For a subject completing the study, the theoretical investigational product application will be 56 consecutive days up to 59 days maximum. The maximal duration of participation for a subject is 68 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anti-aging cosmetic care product | This is an intra-individual comparison study. * frequency of application: Once a day (in the evening) * modalities of application: Apply the cream on the tested area determined by the randomization * duration of investigational product application: 56 days (a window of + 72 hours is allowed) |
Timeline
- Start date
- 2024-05-23
- Primary completion
- 2024-07-26
- Completion
- 2024-07-26
- First posted
- 2024-05-29
- Last updated
- 2024-12-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06433323. Inclusion in this directory is not an endorsement.